Avilex Pharma
Phase 1Avilex Pharma are developing best in class neuroprotectants, exploring an exciting and promising drug target in the brain.
Founded
2015
Focus
RNA & Gene Therapy
About
Avilex Pharma are developing best in class neuroprotectants, exploring an exciting and promising drug target in the brain.
Funding History
2Total raised: $19.5M
Series A$16MNovo HoldingsMar 15, 2023
Seed$3.5MNovo SeedsJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationCopenhagen, Denmark
StagePhase 1
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile